Chemkart India IPO
Chemkart India IPO is a book building of ₹80.08 crores. The issue is a combination of fresh issue of 26.00 lakh shares aggregating to ₹64.48 crores and offer for sale of 6.29 lakh shares aggregating to ₹15.60 crores.
Chemkart India IPO opens for subscription on July 7, 2025 and closes on July 9, 2025. The allotment for the Chemkart India IPO is expected to be finalized on Thursday, July 10, 2025. Chemkart India IPO will be list on BSE SME with a tentative listing date fixed as Monday, July 14, 2025.
Chemkart India IPO price band is set at ₹236 to ₹248 per share. The minimum lot size for an application is 600. The minimum amount of investment required by retail investors is ₹1,41,600. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹2,97,600. The minimum lot size investment for HNI is 3 lots (1,800 shares) amounting to ₹4,46,400.
Smart Horizon Capital Advisors Private Limited is the book-running lead manager of the Chemkart India IPO, while Bigshare Services Pvt Ltd is the registrar for the issue.The market maker for Chemkart India IPO is Alacrity Securities Ltd..
Refer to Chemkart India IPO RHP for detailed information more information visit to newipo.info.
Chemkart India IPO Details
| IPO Date | July 7, 2025 to July 9, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | ₹236 to ₹248 per share |
| Lot Size | 600 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 32,29,200 shares (aggregating up to ₹80.08 Cr) |
| Reserved for Market Maker | 1,66,200 shares (aggregating up to ₹4.12 Cr)Alacrity Securities Ltd. |
| Fresh Issue (Ex Market Maker) | 24,33,800 shares (aggregating up to ₹60.36 Cr) |
| Offer for Sale | 6,29,200 shares of ₹10 (aggregating up to ₹15.60 Cr) |
| Net Offered to Public | 30,63,000 shares (aggregating up to ₹75.96 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 94,99,000 shares |
| Share Holding Post Issue | 1,20,99,000 shares |
Chemkart India IPO Reservation
Chemkart India IPO offers total 32,29,200 shares. Out of which 15,21,000 (47.10%) allocated to QIB, 6,09,600 (18.88%) allocated to QIB, 4,63,200 (14.34%) allocated to NII, 10,78,800 (33.41%) allocated to RII and 9,11,400 (28.22%) allocated to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Retail Shares Offered | 10,78,800 (33.41%) |
| Total Shares Offered | 32,29,200 (100.00%) |
Chemkart India IPO Anchor Investors Details
Chemkart India IPO raises ₹22.60 crore from anchor investors. Chemkart India IPO Anchor bid date is July 4, 2025.
| Bid Date | July 4, 2025 |
| Shares Offered | 9,11,400 |
| Anchor Portion Size (In Cr.) | 22.60 |
| Anchor lock-in period end date for 50% shares (30 Days) | August 9, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | October 8, 2025 |
Chemkart India IPO Timeline (Tentative Schedule)
Chemkart India IPO opens on July 7, 2025, and closes on July 9, 2025.
| IPO Open Date | Mon, Jul 7, 2025 |
| IPO Close Date | Wed, Jul 9, 2025 |
| Tentative Allotment | Thu, Jul 10, 2025 |
| Initiation of Refunds | Fri, Jul 11, 2025 |
| Credit of Shares to Demat | Fri, Jul 11, 2025 |
| Tentative Listing Date | Mon, Jul 14, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 9, 2025 |
Chemkart India IPO Lot Size
Investors can bid for a minimum of 1,200 shares and in multiples of 600 shares there of. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 1,200 | ₹2,97,600 |
| Individual investors (Retail) (Max) | 2 | 1,200 | ₹2,97,600 |
| HNI (Min) | 3 | 1,800 | ₹4,46,400 |
| Lot Size Calculator | |||
Chemkart India IPO Promoter Holding
Mr. Ankit Shaileesh Mehta, Ms. Parul Shaileesh Mehta, and Mr. Shaileesh Vinodrai Mehta are the promoters of the company.
| Share Holding Pre Issue | 100.00% |
| Share Holding Post Issue |
About Chemkart India Limited
Incorporated in 2015, Chemkart India Limited is a distributor specializing in high-quality food and health ingredients. The company bridges the gap between global ingredient manufacturers and businesses across various sectors.
The company targets the B2B platform, providing products for manufacturing supplements like sports, health, vitamins, and protein. Focused on variety, affordability, quality, and customer relationships, it enhances supply chain processes.
The company provides grinding, blending, and packaging services at its hygienic facility in Bhiwandi, Mumbai. The 28,259.16 sq. ft. warehouse is equipped for efficient processing, labeling, and sealing of ingredients.
Products Portfolio:
- Amino Acid: The Building blocks of proteins essential for biological processes and metabolism.
- Health Supplement: Supplements with essential nutrients and bioactive compounds for wellbeing.
- Herbal Extract: Extracts from plants used for therapeutic and functional benefits.
- Nucleotide: Key components supporting immune health, gut health, and nutrition.
- Protein: Vital for muscle growth, immune function, and overall health.
- Sports Nutrition: Ingredients supporting athletic performance, endurance, and recovery.
- Vitamins: Micronutrients essential for various bodily physiological functions.
As of March 31, 2025, the company had 40 employees.
Competitive Strengths:
- Diversified product portfolio
- In house processing and warehousing capabilities
- Value proposition for Customers
Company Financials
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 86.12 | 53.51 | 37.48 |
| Revenue | 205.46 | 132.83 | 131.69 |
| Profit After Tax | 24.26 | 14.52 | 7.66 |
| EBITDA | 32.76 | 20.91 | 11.05 |
| Net Worth | 53.29 | 29.01 | 14.50 |
| Reserves and Surplus | 43.79 | 27.66 | 13.14 |
| Total Borrowing | 17.03 | 12.55 | 11.33 |
| Amount in ₹ Crore | |||
Key Performance Indicator (KPI)
The market capitalization of Chemkart India IPO is ₹300.06 Cr.
KPI as of Mon, Mar 31, 2025.
| KPI | Values |
|---|---|
| ROE | 59% |
| ROCE | 49% |
| Debt/Equity | 0.32 |
| RoNW | 45.52% |
| EBITDA Margin | 16.12% |
| Price to Book Value | 8.12 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 25.54 | 20.05 |
| P/E (x) | 9.71 | 12.3 |